Araujo Lara Colles de Oliva, Kopittke Luciane, Vicari Vinicius
Fundação Oswaldo Cruz, projeto A Hora é Agora, Porto Alegre, RS, Brazil.
Hospital Nossa Senhora da Conceição, Escola GHC, Porto Alegre, RS, Brazil.
Epidemiol Serv Saude. 2024 Dec 16;33(spe1):e2024335. doi: 10.1590/S2237-96222024v33e2024335.especial.en. eCollection 2024.
To describe the prevalence of hormone use, sociodemographic profile, and access to health services among the transgender, transvestite, and nonbinary population in Porto Alegre, capital city of Rio Grande do Sul state.
A cross-sectional study was conducted between September and November 2021, using a snowball sampling method (n=65). Data were collected through a self-administered questionnaire with transgender people aged 18 years or older.
High hormone use was observed (n=47), with a higher occurrence of self-medication among transgender women, transvestites, and transfeminine people (n=10). Health monitoring predominantly occurs in gender identity outpatient clinics (n=56). Episodes of transphobia when accessing health services were reported by 28 individuals.
This study demonstrated high prevalence of hormone use, highlighted specific patterns of use across different gender identities, and the need for improvements in access to healthcare services.
High prevalence of hormone use was observed (n=47), with emphasis on formulations containing estrogen (n=12) or testosterone cypionate (n=22). Self-administered hormone therapy was higher among transgender women, transvestites and transfeminine people (n=10).
This study contributes to understanding the process of self-administered hormone therapy and the need for appropriate interventions. It highlights the importance of establishing strategies that ensure access without discrimination based on gender identity.
Further studies are needed on this topic to encourage the inclusion of medications used in hormone therapy in the National List of Essential Medicines, with the aim of making access to hormones more equitable and universal.
描述巴西南部里奥格兰德州首府阿雷格里港的跨性别者、异装癖者和非二元性别人群中激素使用情况、社会人口学特征以及获得医疗服务的情况。
2021年9月至11月进行了一项横断面研究，采用滚雪球抽样法（n = 65）。通过对18岁及以上的跨性别者进行自填问卷收集数据。
观察到激素使用率较高（n = 47），跨性别女性、异装癖者和跨女性人群中自我用药的发生率更高（n = 10）。健康监测主要在性别认同门诊进行（n = 56）。28人报告了在获得医疗服务时遭遇恐跨症的情况。
本研究表明激素使用率较高，突出了不同性别认同的特定使用模式，以及改善获得医疗服务的必要性。
观察到激素使用率较高（n = 47），重点是含有雌激素的制剂（n = 12）或环戊丙酸睾酮（n = 22）。跨性别女性、异装癖者和跨女性人群中自我激素治疗的比例更高（n = 10）。
本研究有助于了解自我激素治疗的过程以及采取适当干预措施的必要性。它强调了制定确保无性别认同歧视的获得医疗服务策略的重要性。
需要对该主题进行进一步研究，以鼓励将激素治疗中使用的药物纳入国家基本药物清单，目的是使激素的获取更加公平和普遍。
